Chemical shift: the artifact and clinical tool revisited.

The chemical shift phenomenon refers to the signal intensity alterations seen in magnetic resonance (MR) imaging that result from the inherent differences in the resonant frequencies of precessing protons. Chemical shift was first recognized as a misregistration artifact of image data. More recently, however, chemical shift has been recognized as a useful diagnostic tool. By exploiting inherent differences in resonant frequencies of lipid and water, fatty elements within tissue can be confirmed with dedicated chemical shift MR pulse sequences. Alternatively, the recognition of chemical shift on images obtained with standard MR pulse sequences may corroborate the diagnosis of lesions with substantial fatty elements. Chemical shift can aid in the diagnosis of lipid-containing lesions of the brain (lipoma, dermoid, and teratoma) or the body (adrenal adenoma, focal fat within the liver, and angiomyolipoma). In addition, chemical shift can be implemented to accentuate visceral margins (e.g., kidney and liver).

[1]  L. Brateman.  Chemical shift imaging: a review. , 1986, AJR. American journal of roentgenology.

[2]  J. Smirniotopoulos,et al.  Teratomas, dermoids, and epidermoids of the head and neck. , 1995, Radiographics : a review publication of the Radiological Society of North America, Inc.

[3]  W. Steinbrich,et al.  Adrenal masses: evaluation with fast gradient-echo MR imaging and Gd-DTPA-enhanced dynamic studies. , 1989, Radiology.

[4]  D. Mitchell,et al.  Fatty Liver: Chemical Shift Phas and Suppression Magnetic Resonance Imaging Techniques in Animals, Phantoms, and Humans , 1991 .

[5]  C. Truwit,et al.  Pathogenesis of intracranial lipoma: an MR study in 42 patients. , 1990, AJNR. American journal of neuroradiology.

[6]  W. Bradley.  MR appearance of hemorrhage in the brain. , 1993, Radiology.

[7]  D. Faul,et al.  Proton chemical shift imaging. , 1986, Diagnostic imaging in clinical medicine.

[8]  R. Lange,et al.  Chemical shift artifact: dependence on shape and orientation of the lipid-water interface. , 1991, Radiology.

[9]  M. Bernardino,et al.  The Fatty Liver: Pitfalls in the CT and Angiographic Evaluation of Metastatic Disease , 1983, Journal of computer assisted tomography.

[10]  H. Hricak,et al.  Lipomatous tumors and tumors with fatty component: MR imaging potential and comparison of MR and CT results. , 1985, Radiology.

[11]  T. Foster,et al.  Reduced-bandwidth MR imaging of the head at 1.5 T1. , 1989, Radiology.

[12]  N. Rofsky,et al.  Comparison between in-phase and opposed-phase T1-weighted breath-hold FLASH sequences for hepatic imaging. , 1996, Journal of computer assisted tomography.

[13]  M. Fukuoka,et al.  Intracranial lipomas: current perspectives in their diagnosis and treatment. , 1992, British journal of neurosurgery.

[14]  P. Hahn,et al.  An imaging algorithm for the differential diagnosis of adrenal adenomas and metastases. , 1995, AJR. American journal of roentgenology.

[15]  M. Sentís,et al.  Fatty metamorphosis of hepatocellular carcinoma: detection with chemical shift gradient-echo MR imaging. , 1995, Radiology.

[16]  H. Ishizaka,et al.  Adrenal masses: differentiation with chemical shift, fast low-angle shot MR imaging. , 1993, Radiology.

[17]  R. Henkelman,et al.  High signal intensity in MR images of calcified brain tissue. , 1991, Radiology.

[18]  Krestin Gp,et al.  Magnetic resonance imaging of the kidneys: current status. , 1994 .

[19]  D. Mitchell,et al.  Hepatocellular tumors with high signal on T1-weighted MR images: chemical shift MR imaging and histologic correlation. , 1991, Journal of computer assisted tomography.

[20]  J. Roucayrol,et al.  In vivo MR spectroscopic imaging of the adrenal glands: distinction between adenomas and carcinomas larger than 15 mm based on lipid content. , 1989, AJR. American journal of roentgenology.

[21]  D. Mitchell,et al.  Fatty tissue on opposed-phase MR images: paradoxical suppression of signal intensity by paramagnetic contrast agents. , 1996, Radiology.

[22]  H. K. Lee,et al.  Correction for chemical‐shift artifacts in 19F imaging of PFOB: Simultaneous multislice imaging , 1991, Magnetic resonance in medicine.

[23]  P M Parizel,et al.  Understanding chemical shift induced boundary artefacts as a function of field strength: influence of imaging parameters (bandwidth, field-of-view, and matrix size). , 1994, European journal of radiology.

[24]  D. Mitchell.  Chemical shift magnetic resonance imaging: Applications in the abdomen and pelvis , 1992, Topics in magnetic resonance imaging : TMRI.

[25]  D. Mitchell,et al.  Benign adrenocortical masses: diagnosis with chemical shift MR imaging. , 1992, Radiology.

[26]  D. Mitchell,et al.  Distinction between benign and malignant adrenal masses: value of T1-weighted chemical-shift MR imaging. , 1995, AJR. American journal of roentgenology.

[27]  L. Quint,et al.  Adrenal adenomas: relationship between histologic lipid and CT and MR findings. , 1996, Radiology.

[28]  S. Saini,et al.  Characterization of adrenal masses (< 5 cm) by use of chemical shift MR imaging: observer performance versus quantitative measures. , 1995, AJR. American journal of roentgenology.

[29]  A. Smith,et al.  Intracranial chemical-shift artifacts on MR images of the brain: observations and relation to sampling bandwidth. , 1990, AJR. American journal of roentgenology.

[30]  D. Mitchell,et al.  Focal manifestations of diffuse liver disease at MR imaging. , 1992, Radiology.

[31]  R. Edelman,et al.  Clinical magnetic resonance imaging , 1990 .

[32]  L. Hayman,et al.  Artifacts and pitfalls in MR imaging of the orbit: a clinical review. , 1997, Radiographics : a review publication of the Radiological Society of North America, Inc.

[33]  E. Outwater,et al.  Adrenal masses: correlation between CT attenuation value and chemical shift ratio at MR imaging with in-phase and opposed-phase sequences. , 1996, Radiology.

[34]  J. Weinreb,et al.  Edge Artifacts in MR Images: Chemical Shift Effect , 1985, Journal of computer assisted tomography.

[35]  C. Caldwell,et al.  Differentiation of adrenal masses with MR imaging: comparison of techniques. , 1994, Radiology.

[36]  D. Mitchell,et al.  Fatty liver. Chemical shift phase-difference and suppression magnetic resonance imaging techniques in animals, phantoms, and humans. , 1991, Investigative radiology.

[37]  J. Heiken,et al.  Primary bladder carcinoma: evaluation with MR imaging. , 1987, Radiology.

[38]  A M Aisen,et al.  Characterization of adrenal masses with chemical shift and gadolinium-enhanced MR imaging. , 1995, Radiology.

[39]  J. Singer,et al.  MR imaging of adrenal masses: value of chemical-shift imaging for distinguishing adenomas from other tumors. , 1995, AJR. American journal of roentgenology.

[40]  A. Shimakawa,et al.  Chemical shift-induced amplitude modulations in images obtained with gradient refocusing. , 1987, Magnetic resonance imaging.

[41]  J H Simon,et al.  Proton (fat/water) chemical shift imaging in medical magnetic resonance imaging. Current status. , 1992, Investigative radiology.

[42]  M. Apuzzo,et al.  MR imaging of pineal region neoplasms. , 1991, Journal of computer assisted tomography.

[43]  L. Schwartz,et al.  Adrenal masses in patients with malignancy: prospective comparison of echo-planar, fast spin-echo, and chemical shift MR imaging. , 1995, Radiology.

[44]  G. Krestin,et al.  Magnetic resonance imaging of the kidneys: current status. , 1994, Magnetic resonance quarterly.

[45]  R. Shifrin,et al.  Metastatic adenocarcinoma within an adrenal adenoma: detection with chemical shift imaging. , 1996, AJR. American journal of roentgenology.